BioSpace News Archive

Business

Castle Biosciences Reports Second Quarter 2023 Results

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the second quarter and six months ended June 30, 2023.

August 2, 2023
·
27 min read
Lone Star Bio

Maxwell Biosciences Announces Publication of Mechanism of Action Study: Claromer Compounds Target Pathogens by Disrupting Their Membranes

Maxwell Biosciences, a pioneering preclinical drug platform company, today announced publication of a revolutionary mechanism of action study for their Claromer® compounds in the journal ACS Infectious Diseases.

August 2, 2023
·
4 min read
Business

McKesson Corporation Reports Fiscal 2024 First Quarter Results

McKesson Corporation has released its fiscal 2024 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.

August 2, 2023
·
1 min read
Business

BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today announced that the Company will host a conference call and a live audio webcast on Wednesday, August 9th, 2023, at 8:00 a.m. ET, to report second quarter 2023 financial results and provide business updates.

August 2, 2023
·
1 min read
Biotech Bay

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 02, 2023

Olema Pharmaceuticals, Inc. announced that the Company granted stock options to two new employees to purchase an aggregate of 29,100 shares of the Company’s common stock, effective as of August 1, 2023.

August 2, 2023
·
2 min read
Business

Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow

Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its second quarter 2023 financial results after market close on Wednesday, August 9, 2023.

August 2, 2023
·
2 min read
Business

Dentsply Sirona Reports Second Quarter 2023 Results

Second quarter net sales of $1,028 million increased 0.5%, compared to $1,023 million in the second quarter of 2022.

August 2, 2023
·
23 min read
MedinCell’s Partner Teva Announces Successful Launch of UZEDY™

Richard Francis, President and CEO of Teva, and Eric Hughes, Executive Vice President, Global R&D & Chief Medical Officer, commented the US launch of UZEDY since May 2023 and the olanzapine Long-Acting Injectable.

August 2, 2023
·
3 min read
Business

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today provides a business update and announces financial results for the second quarter of 2023, ended June 30, 2023.

August 2, 2023
·
7 min read
Biotech Beach

Children’s Hospital of Orange County neonatologist Dr. Terrie Inder’s study on preterm brains published in New England Journal of Medicine

According to a review paper published in a recent issue of the New England Journal of Medicine, preterm babies face a high risk of long-term neurological and developmental disabilities, despite health care advances that are keeping them and very preterm infants alive.

August 2, 2023
·
3 min read